Sign in
0IDA Stock Price, Chart, Stats & News
Dynavax Technologies Corporation
Save
Dynavax Technologies Corporation (0IDA) does not currently pay a dividend.
1.82B
Market cap
20.57x
Current P/E
–
Forward P/E
0IDA chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Dynavax Technologies Corporation operates as a biopharmaceutical firm, primarily dedicated to the research, development, and commercialization of innovative vaccines within the United States. Its leading product is HEPLISAV-B, a hepatitis B vaccine available in both the U. S. and European markets, designed to protect adults aged 18 and above from all known subtypes of the hepatitis B virus.
Similar securities
Based on sector and market capitalization
Report issue